Could MDMA Be A Frontline Therapeutic For Women’s Sexual Disorders? MINDCURE CEO Kelsey Ramsden Says Yes Sep 29, 2021
MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted… Sep 27, 2021
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers Sep 23, 2021
MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental Health Industry Sep 16, 2021
